| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 6-phosphofructokinase activity | 3.12e-05 | 3 | 65 | 2 | GO:0003872 | |
| GeneOntologyMolecularFunction | fructose-6-phosphate binding | 1.04e-04 | 5 | 65 | 2 | GO:0070095 | |
| GeneOntologyMolecularFunction | fructose binding | 1.55e-04 | 6 | 65 | 2 | GO:0070061 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 2.17e-04 | 7 | 65 | 2 | GO:0008443 | |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 4.62e-04 | 10 | 65 | 2 | GO:0005432 | |
| GeneOntologyMolecularFunction | calcium ion binding | 6.83e-04 | 749 | 65 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 7.95e-04 | 13 | 65 | 2 | GO:0015368 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.72e-05 | 187 | 65 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 5.68e-05 | 313 | 65 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | calcium ion export | 5.84e-05 | 4 | 65 | 2 | GO:1901660 | |
| GeneOntologyCellularComponent | 6-phosphofructokinase complex | 2.85e-05 | 3 | 65 | 2 | GO:0005945 | |
| GeneOntologyCellularComponent | phagophore assembly site | 2.42e-04 | 39 | 65 | 3 | GO:0000407 | |
| MousePheno | abnormal fluid regulation | DNAAF2 KRT2 NPR1 SLC8A1 FBN1 ADAMTS3 JMJD6 NUP133 MLLT10 RB1CC1 MYO18B NFAT5 TP73 FAN1 | 1.57e-06 | 826 | 53 | 14 | MP:0001784 |
| MousePheno | abnormal heart ventricle morphology | LRIG3 THBS1 NPR1 SLC8A1 FBN1 ADAMTS3 JMJD6 FAT3 FNIP1 RB1CC1 PFKM NFAT5 | 3.16e-05 | 793 | 53 | 12 | MP:0005294 |
| MousePheno | abnormal muscle morphology | ADAMTS10 LRIG3 THBS1 NPR1 SLC8A1 FBN1 JMJD6 FAT3 FNIP1 RB1CC1 MYO18B PFKM NFAT5 CD163 | 4.45e-05 | 1106 | 53 | 14 | MP:0002108 |
| MousePheno | edema | DNAAF2 NPR1 SLC8A1 ADAMTS3 JMJD6 NUP133 MLLT10 RB1CC1 NFAT5 TP73 | 5.52e-05 | 581 | 53 | 10 | MP:0001785 |
| MousePheno | abnormal blood circulation | LRIG3 THBS1 NPR1 SLC8A1 FBN1 ADAMTS3 ARID4A FNIP1 MLLT10 RB1CC1 MYO18B TP73 | 5.87e-05 | 845 | 53 | 12 | MP:0002128 |
| MousePheno | abnormal cardiac muscle tissue morphology | 8.19e-05 | 489 | 53 | 9 | MP:0010630 | |
| MousePheno | abnormal respiratory system physiology | DNAAF2 THBS1 NPR1 FBN1 ARID4A CADPS FAT3 FNIP1 IKZF1 PTGER2 CD163 TP73 | 1.04e-04 | 897 | 53 | 12 | MP:0002133 |
| MousePheno | abnormal heart ventricle wall morphology | 1.19e-04 | 296 | 53 | 7 | MP:0031532 | |
| MousePheno | increased lung compliance | 1.26e-04 | 26 | 53 | 3 | MP:0010895 | |
| MousePheno | abnormal gland physiology | 2.31e-04 | 691 | 53 | 10 | MP:0002164 | |
| MousePheno | abnormal endocrine gland morphology | LRIG3 THBS1 SLC8A1 FBN1 BRCA1 ADAMTS3 JMJD6 FAT3 FNIP1 IKZF1 NFAT5 WDR13 TP73 | 2.63e-04 | 1144 | 53 | 13 | MP:0013560 |
| MousePheno | fetal cardiomyocyte disarray | 2.93e-04 | 7 | 53 | 2 | MP:0031613 | |
| Domain | PCDHB2/3 | 1.16e-05 | 2 | 64 | 2 | IPR030735 | |
| Domain | PHOSPHOFRUCTOKINASE | 3.46e-05 | 3 | 64 | 2 | PS00433 | |
| Domain | 6-Pfructokinase_euk | 3.46e-05 | 3 | 64 | 2 | IPR009161 | |
| Domain | Phosphofructokinase_CS | 3.46e-05 | 3 | 64 | 2 | IPR015912 | |
| Domain | PFK | 3.46e-05 | 3 | 64 | 2 | PF00365 | |
| Domain | ATP_PFK | 3.46e-05 | 3 | 64 | 2 | IPR022953 | |
| Domain | Phosphofructokinase_dom | 3.46e-05 | 3 | 64 | 2 | IPR000023 | |
| Domain | Cadherin_CS | 3.58e-05 | 109 | 64 | 5 | IPR020894 | |
| Domain | CADHERIN_1 | 4.25e-05 | 113 | 64 | 5 | PS00232 | |
| Domain | Cadherin | 4.25e-05 | 113 | 64 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 4.44e-05 | 114 | 64 | 5 | PS50268 | |
| Domain | - | 4.44e-05 | 114 | 64 | 5 | 2.60.40.60 | |
| Domain | CA | 4.63e-05 | 115 | 64 | 5 | SM00112 | |
| Domain | Cadherin-like | 4.82e-05 | 116 | 64 | 5 | IPR015919 | |
| Domain | Cadherin | 5.23e-05 | 118 | 64 | 5 | IPR002126 | |
| Domain | EGF-like_CS | 2.67e-04 | 261 | 64 | 6 | IPR013032 | |
| Domain | EGF_2 | 2.90e-04 | 265 | 64 | 6 | PS01186 | |
| Domain | EGF_3 | 1.26e-03 | 235 | 64 | 5 | PS50026 | |
| Domain | EGF | 1.26e-03 | 235 | 64 | 5 | SM00181 | |
| Domain | TSP_1 | 1.32e-03 | 63 | 64 | 3 | PF00090 | |
| Domain | TSP1 | 1.44e-03 | 65 | 64 | 3 | SM00209 | |
| Domain | TSP1_rpt | 1.44e-03 | 65 | 64 | 3 | IPR000884 | |
| Domain | TSP1 | 1.44e-03 | 65 | 64 | 3 | PS50092 | |
| Domain | Cadherin_2 | 1.44e-03 | 65 | 64 | 3 | PF08266 | |
| Domain | Cadherin_N | 1.44e-03 | 65 | 64 | 3 | IPR013164 | |
| Domain | A/G_cyclase_CS | 1.52e-03 | 17 | 64 | 2 | IPR018297 | |
| Domain | EGF-like_dom | 1.63e-03 | 249 | 64 | 5 | IPR000742 | |
| Domain | Nucleotide_cyclase | 1.71e-03 | 18 | 64 | 2 | IPR029787 | |
| Domain | - | 1.71e-03 | 18 | 64 | 2 | 3.30.70.1230 | |
| Domain | EGF_1 | 1.80e-03 | 255 | 64 | 5 | PS00022 | |
| Domain | PLAC | 1.90e-03 | 19 | 64 | 2 | PS50900 | |
| Domain | GUANYLATE_CYCLASE_1 | 1.90e-03 | 19 | 64 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 1.90e-03 | 19 | 64 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 1.90e-03 | 19 | 64 | 2 | PS50125 | |
| Domain | PLAC | 1.90e-03 | 19 | 64 | 2 | IPR010909 | |
| Domain | A/G_cyclase | 1.90e-03 | 19 | 64 | 2 | IPR001054 | |
| Domain | CYCc | 1.90e-03 | 19 | 64 | 2 | SM00044 | |
| Domain | ADAM_spacer1 | 2.79e-03 | 23 | 64 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.79e-03 | 23 | 64 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.04e-03 | 24 | 64 | 2 | IPR013273 | |
| Domain | EGF_CA | 3.21e-03 | 86 | 64 | 3 | PF07645 | |
| Domain | - | 4.24e-03 | 95 | 64 | 3 | 2.60.120.200 | |
| Pubmed | FIP200 regulates targeting of Atg16L1 to the isolation membrane. | 5.19e-07 | 9 | 65 | 3 | 23392225 | |
| Pubmed | 9.26e-07 | 407 | 65 | 8 | 12693553 | ||
| Pubmed | Exome sequencing supports a de novo mutational paradigm for schizophrenia. | 9.65e-07 | 40 | 65 | 4 | 21822266 | |
| Pubmed | 1.07e-06 | 285 | 65 | 7 | 34369648 | ||
| Pubmed | 1.35e-06 | 12 | 65 | 3 | 24954904 | ||
| Pubmed | 3.43e-06 | 16 | 65 | 3 | 7633422 | ||
| Pubmed | Insulin specifically regulates expression of liver and muscle phosphofructokinase isoforms. | 3.44e-06 | 2 | 65 | 2 | 29655163 | |
| Pubmed | CCCP-Induced LC3 lipidation depends on Atg9 whereas FIP200/Atg13 and Beclin 1/Atg14 are dispensable. | 3.44e-06 | 2 | 65 | 2 | 23402761 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 21525242 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 8780720 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 36892222 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 6444532 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 27815209 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 20807817 | ||
| Pubmed | Ultrastructural analysis of autophagosome organization using mammalian autophagy-deficient cells. | 3.44e-06 | 2 | 65 | 2 | 25052093 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 21402694 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 30409970 | ||
| Pubmed | The glycolytic enzyme phosphofructokinase-1 assembles into filaments. | 3.44e-06 | 2 | 65 | 2 | 28646105 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ADAMTS10 FBH1 ARID4A SANBR HACL1 ATG9A ZNF236 ADCY3 TP73 FAN1 | 8.04e-06 | 925 | 65 | 10 | 28986522 |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 7825568 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 30201140 | ||
| Pubmed | FIP200 Claw Domain Binding to p62 Promotes Autophagosome Formation at Ubiquitin Condensates. | 1.03e-05 | 3 | 65 | 2 | 30853400 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 6444721 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 11137296 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 37116593 | ||
| Pubmed | Phosphofructokinase isozyme expression during myoblast differentiation. | 1.03e-05 | 3 | 65 | 2 | 2521854 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 33141153 | ||
| Pubmed | Phosphofructokinase (PFK) isozymes in man. I. Studies of adult human tissues. | 1.03e-05 | 3 | 65 | 2 | 156693 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 6451249 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 21157449 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 34903812 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 32580962 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 28634261 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 2960695 | ||
| Pubmed | FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. | 1.03e-05 | 3 | 65 | 2 | 20716775 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 30254632 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 29938573 | ||
| Pubmed | 1.13e-05 | 156 | 65 | 5 | 32850835 | ||
| Pubmed | Methylation biomarkers for pleomorphic lobular breast cancer - a short report. | 2.06e-05 | 4 | 65 | 2 | 26392358 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 20301293 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 20616007 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 2.63e-05 | 91 | 65 | 4 | 28558017 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 3.08e-05 | 321 | 65 | 6 | 32098917 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 21344162 | ||
| Pubmed | Sestrin2 promotes Unc-51-like kinase 1 mediated phosphorylation of p62/sequestosome-1. | 3.43e-05 | 5 | 65 | 2 | 25040165 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 31169361 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | KRT2 WASHC4 DSC3 SQSTM1 DNAJA2 SHCBP1 NUP133 PFKL PFKM WDR13 SLC3A2 | 3.85e-05 | 1353 | 65 | 11 | 29467282 |
| Pubmed | 4.01e-05 | 1116 | 65 | 10 | 31753913 | ||
| Pubmed | 4.85e-05 | 513 | 65 | 7 | 25798074 | ||
| Pubmed | RB1CC1 protein suppresses type II collagen synthesis in chondrocytes and causes dwarfism. | 5.13e-05 | 6 | 65 | 2 | 22049074 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 26929451 | ||
| Pubmed | The tight-skin (Tsk) mutation is closely linked to B2m on mouse chromosome 2. | 5.13e-05 | 6 | 65 | 2 | 8111131 | |
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 5.13e-05 | 6 | 65 | 2 | 12767889 | |
| Pubmed | 5.15e-05 | 214 | 65 | 5 | 22199357 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 28322253 | ||
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 9.09e-05 | 125 | 65 | 4 | 21654808 | |
| Pubmed | Retinal transcriptome of neonatal mice after optic nerve injury. | 9.56e-05 | 8 | 65 | 2 | 37252932 | |
| Pubmed | Critical role of mitochondrial ubiquitination and the OPTN-ATG9A axis in mitophagy. | 9.56e-05 | 8 | 65 | 2 | 32556086 | |
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 33296658 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 21074528 | ||
| Pubmed | 1.29e-04 | 1285 | 65 | 10 | 35914814 | ||
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 31142229 | ||
| Pubmed | N-terminal arginylation generates a bimodal degron that modulates autophagic proteolysis. | 1.53e-04 | 10 | 65 | 2 | 29507222 | |
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 26764600 | ||
| Pubmed | p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. | 1.53e-04 | 10 | 65 | 2 | 21220506 | |
| Pubmed | Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin. | 1.53e-04 | 10 | 65 | 2 | 24100292 | |
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 11167130 | ||
| Pubmed | Genetic variants associated with breast size also influence breast cancer risk. | 1.70e-04 | 57 | 65 | 3 | 22747683 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.70e-04 | 57 | 65 | 3 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 1.79e-04 | 58 | 65 | 3 | 30377227 | |
| Pubmed | Atg9a deficiency causes axon-specific lesions including neuronal circuit dysgenesis. | 1.87e-04 | 11 | 65 | 2 | 28513333 | |
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 26764599 | ||
| Pubmed | 1.88e-04 | 282 | 65 | 5 | 23667531 | ||
| Pubmed | 2.08e-04 | 61 | 65 | 3 | 32911434 | ||
| Pubmed | 2.58e-04 | 1139 | 65 | 9 | 36417873 | ||
| Pubmed | 2.65e-04 | 13 | 65 | 2 | 12231349 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 2.86e-04 | 68 | 65 | 3 | 11230163 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 2.86e-04 | 1155 | 65 | 9 | 20360068 | |
| Pubmed | FIP200 is required for maintenance and differentiation of postnatal neural stem cells. | 3.08e-04 | 14 | 65 | 2 | 23542691 | |
| Pubmed | 3.08e-04 | 14 | 65 | 2 | 23447624 | ||
| Pubmed | FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation. | 3.08e-04 | 14 | 65 | 2 | 25126726 | |
| Pubmed | 3.08e-04 | 14 | 65 | 2 | 33436498 | ||
| Pubmed | 3.25e-04 | 71 | 65 | 3 | 33541421 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 3.39e-04 | 72 | 65 | 3 | 10380929 | |
| Pubmed | Huntingtin functions as a scaffold for selective macroautophagy. | 3.56e-04 | 15 | 65 | 2 | 25686248 | |
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 26235979 | ||
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 3.56e-04 | 15 | 65 | 2 | 38871984 | |
| Pubmed | 3.60e-04 | 504 | 65 | 6 | 34432599 | ||
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 3.67e-04 | 74 | 65 | 3 | 10817752 | |
| Pubmed | 3.82e-04 | 75 | 65 | 3 | 20637190 | ||
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 24639535 | ||
| Pubmed | 4.13e-04 | 77 | 65 | 3 | 10835267 | ||
| Pubmed | 4.43e-04 | 340 | 65 | 5 | 29478914 | ||
| Pubmed | ATF4 May Be Essential for Adaption of the Ocular Lens to Its Avascular Environment. | 4.59e-04 | 17 | 65 | 2 | 37998373 | |
| Pubmed | Mapping of five subtype genes for muscarinic acetylcholine receptor to mouse chromosomes. | 4.59e-04 | 17 | 65 | 2 | 10549128 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 4.62e-04 | 80 | 65 | 3 | 10716726 | |
| Pubmed | Proteomic analysis identifies novel binding partners of BAP1. | 4.62e-04 | 80 | 65 | 3 | 34591877 | |
| Pubmed | High-throughput screening of functional deubiquitinating enzymes in autophagy. | 5.16e-04 | 18 | 65 | 2 | 32453962 | |
| Pubmed | 5.16e-04 | 18 | 65 | 2 | 28049690 | ||
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 5.16e-04 | 18 | 65 | 2 | 35503090 | |
| Interaction | ITIH5 interactions | 8.95e-06 | 13 | 65 | 3 | int:ITIH5 | |
| Interaction | APEH interactions | 8.99e-06 | 87 | 65 | 5 | int:APEH | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q11 | 1.29e-04 | 12 | 65 | 2 | chr16q11 | |
| Cytoband | 5q31 | 5.97e-04 | 115 | 65 | 3 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 8.63e-04 | 298 | 65 | 4 | chr5q31 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.27e-04 | 181 | 49 | 5 | 694 | |
| GeneFamily | Clustered protocadherins | 6.94e-04 | 64 | 49 | 3 | 20 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.19e-03 | 19 | 49 | 2 | 50 | |
| GeneFamily | Autophagy related | 3.60e-03 | 33 | 49 | 2 | 1022 | |
| Coexpression | GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 9.82e-06 | 198 | 65 | 6 | M5346 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN | 1.01e-05 | 199 | 65 | 6 | M6172 | |
| Coexpression | KANG_DOXORUBICIN_RESISTANCE_DN | 1.37e-05 | 19 | 65 | 3 | M3323 | |
| Coexpression | OHM_METHYLATED_IN_ADULT_CANCERS | 4.08e-05 | 27 | 65 | 3 | M1233 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | THBS1 DSC3 ADAMTS3 ARID4A CADPS FAT3 TENM1 NUP133 PCDHB3 FNIP1 ASTN1 ICE1 | 6.39e-06 | 836 | 64 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| ToppCell | (07)_Ionocytes-(1)_GFP|(07)_Ionocytes / shred by cell type by condition | 2.45e-06 | 147 | 65 | 5 | d398f49553ece2786c51e16e4bee028fb3833149 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.35e-06 | 189 | 65 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.79e-06 | 191 | 65 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 192 | 65 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.48e-06 | 194 | 65 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 65 | 5 | 6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 65 | 5 | 1aa99d21bf61b86df4a966dc47634044430aa39f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Ptgfr_(Postsubiculum)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.29e-05 | 98 | 65 | 4 | 9865a9de11dea6db0b75dd04fee523cd2da44766 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 127 | 65 | 4 | 39fa20a55de3af1a62ab5dfa4877879db3935ac2 | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.79e-05 | 155 | 65 | 4 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | Adult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor | 9.02e-05 | 161 | 65 | 4 | 44f5c0256b3ce264a6c7b62740f32dcd45ee052d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 162 | 65 | 4 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 168 | 65 | 4 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 168 | 65 | 4 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 169 | 65 | 4 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.11e-04 | 170 | 65 | 4 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 170 | 65 | 4 | 8465c3069bbc08705d070927e712b6bc85ac7c5b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 175 | 65 | 4 | 06eace2e681980456299167b48bd49bcfea5e940 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 175 | 65 | 4 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 175 | 65 | 4 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 178 | 65 | 4 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 180 | 65 | 4 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 180 | 65 | 4 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.48e-04 | 183 | 65 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 183 | 65 | 4 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 1.48e-04 | 183 | 65 | 4 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.48e-04 | 183 | 65 | 4 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 184 | 65 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 185 | 65 | 4 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 185 | 65 | 4 | a6874dd3030d04380cc3c01de1069461aad4ef45 | |
| ToppCell | mild-unassigned|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.57e-04 | 186 | 65 | 4 | 5b2e1a58916f392fa1156bf9210df528775248ff | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.64e-04 | 188 | 65 | 4 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.64e-04 | 188 | 65 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.64e-04 | 188 | 65 | 4 | 0e2d1b21f0a7ee306e7dae16fc8c19d16a467883 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 189 | 65 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 189 | 65 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 189 | 65 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.71e-04 | 190 | 65 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 191 | 65 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.74e-04 | 191 | 65 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 191 | 65 | 4 | 468b5149d1533f03521844d3cce8633d44eb6ed4 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.78e-04 | 192 | 65 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 192 | 65 | 4 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-04 | 192 | 65 | 4 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-04 | 192 | 65 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 192 | 65 | 4 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-04 | 192 | 65 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-04 | 192 | 65 | 4 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-04 | 192 | 65 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 193 | 65 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-04 | 193 | 65 | 4 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 194 | 65 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 194 | 65 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 195 | 65 | 4 | ce8215d503cad3a9bc7d5d2be4adb57408015593 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-04 | 195 | 65 | 4 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-04 | 197 | 65 | 4 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.96e-04 | 197 | 65 | 4 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.00e-04 | 198 | 65 | 4 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.00e-04 | 198 | 65 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.00e-04 | 198 | 65 | 4 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.00e-04 | 198 | 65 | 4 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 198 | 65 | 4 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-04 | 198 | 65 | 4 | 885cbd3695b466a161cf318d35ebbdfcc0c19cec | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.00e-04 | 198 | 65 | 4 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-Cilia-bearing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.04e-04 | 199 | 65 | 4 | 2d8ab4aee300c7c4baf662940ce855da2b6d2cae | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.04e-04 | 199 | 65 | 4 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 199 | 65 | 4 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Transverse / Region, Cell class and subclass | 2.08e-04 | 200 | 65 | 4 | f588d8889f351c797963616a3575fa43efd46b9a | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.08e-04 | 200 | 65 | 4 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(52)_cycling_DCs|Transverse / shred on region, Cell_type, and subtype | 2.08e-04 | 200 | 65 | 4 | 51e643d48b5e97a0e117b578a6ea7d429c6cdd1e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-04 | 200 | 65 | 4 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| Computational | Neighborhood of TFDP2 | 3.66e-05 | 230 | 44 | 7 | MORF_TFDP2 | |
| Computational | Neighborhood of ERCC4 | 2.94e-04 | 321 | 44 | 7 | MORF_ERCC4 | |
| Computational | Neighborhood of IL16 | 3.95e-04 | 239 | 44 | 6 | MORF_IL16 | |
| Computational | Neighborhood of NF1 | 6.15e-04 | 170 | 44 | 5 | MORF_NF1 | |
| Computational | Neighborhood of BRCA1 | 6.55e-04 | 263 | 44 | 6 | MORF_BRCA1 | |
| Computational | Neighborhood of PPP2R5B | 6.66e-04 | 173 | 44 | 5 | MORF_PPP2R5B | |
| Computational | Neighborhood of MDM2 | 8.92e-04 | 279 | 44 | 6 | MORF_MDM2 | |
| Computational | Neighborhood of BCL2L11 | 9.24e-04 | 186 | 44 | 5 | MORF_BCL2L11 | |
| Computational | Neighborhood of BNIP1 | 1.02e-03 | 190 | 44 | 5 | MORF_BNIP1 | |
| Computational | Neighborhood of CASP10 | 1.29e-03 | 117 | 44 | 4 | MORF_CASP10 | |
| Computational | Neighborhood of MLLT10 | 1.34e-03 | 302 | 44 | 6 | MORF_MLLT10 | |
| Computational | Neighborhood of ARL3 | 1.39e-03 | 304 | 44 | 6 | MORF_ARL3 | |
| Computational | Neighborhood of ATF2 | 2.11e-03 | 330 | 44 | 6 | MORF_ATF2 | |
| Disease | Weill-Marchesani syndrome | 1.30e-05 | 3 | 62 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 1.30e-05 | 3 | 62 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 1.30e-05 | 3 | 62 | 2 | C1869114 | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 1.30e-05 | 3 | 62 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | glycogen storage disease (implicated_via_orthology) | 2.60e-05 | 4 | 62 | 2 | DOID:2747 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 2.60e-05 | 4 | 62 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 2.60e-05 | 4 | 62 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | vital capacity | ADAMTS10 THBS1 SLC8A1 ADAMTS3 PCDHA1 MLLT10 MAPKBP1 MYO18B SDR16C5 NFAT5 ADCY3 | 4.75e-05 | 1236 | 62 | 11 | EFO_0004312 |
| Disease | body weight | ADAMTS10 ADAMTS3 NBEAL1 CADPS HDX FNIP1 PCDHA1 DCST2 MLLT10 SDR16C5 ATP2B4 | 5.69e-05 | 1261 | 62 | 11 | EFO_0004338 |
| Disease | grip strength measurement | 9.38e-05 | 350 | 62 | 6 | EFO_0006941 | |
| Disease | waist-hip ratio | ADAMTS10 ARID4A CADPS DCST2 MLLT10 MAPKBP1 NFAT5 ATP2B4 ADCY3 TP73 | 2.22e-04 | 1226 | 62 | 10 | EFO_0004343 |
| Disease | comparative body size at age 10, self-reported | 2.52e-04 | 420 | 62 | 6 | EFO_0009819 | |
| Disease | non-lobar intracerebral hemorrhage | 3.21e-04 | 63 | 62 | 3 | EFO_0010178 | |
| Disease | neuroimaging measurement | 3.75e-04 | 1069 | 62 | 9 | EFO_0004346 | |
| Disease | Malignant neoplasm of breast | 3.88e-04 | 1074 | 62 | 9 | C0006142 | |
| Disease | Diabetic Angiopathies | 5.11e-04 | 16 | 62 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 5.11e-04 | 16 | 62 | 2 | C0025945 | |
| Disease | disease free survival | 6.50e-04 | 18 | 62 | 2 | EFO_0000409 | |
| Disease | diet measurement, HOMA-B | 7.26e-04 | 19 | 62 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | Mammary Carcinoma, Human | 8.16e-04 | 525 | 62 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 8.16e-04 | 525 | 62 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 8.32e-04 | 527 | 62 | 6 | C1458155 | |
| Disease | Headache, HbA1c measurement | 8.89e-04 | 21 | 62 | 2 | EFO_0004541, HP_0002315 | |
| Disease | disease of metabolism (implicated_via_orthology) | 8.89e-04 | 21 | 62 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | BREAST CANCER | 8.89e-04 | 21 | 62 | 2 | 114480 | |
| Disease | Breast Carcinoma | 9.25e-04 | 538 | 62 | 6 | C0678222 | |
| Disease | Nephritis, Interstitial | 1.16e-03 | 24 | 62 | 2 | C0027707 | |
| Disease | stomach carcinoma (is_marker_for) | 1.16e-03 | 24 | 62 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Endogenous Hyperinsulinism | 1.37e-03 | 26 | 62 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 1.37e-03 | 26 | 62 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 1.37e-03 | 26 | 62 | 2 | C1257965 | |
| Disease | Glycogen Storage Disease | 1.47e-03 | 27 | 62 | 2 | C0017919 | |
| Disease | Malignant tumor of breast | 1.47e-03 | 27 | 62 | 2 | cv:C0006142 | |
| Disease | Breast neoplasm | 1.47e-03 | 27 | 62 | 2 | cv:C1458155 | |
| Disease | Familial cancer of breast | 1.47e-03 | 27 | 62 | 2 | cv:C0346153 | |
| Disease | Hyperinsulinism | 1.59e-03 | 28 | 62 | 2 | C0020459 | |
| Disease | Hyperglycemia, Postprandial | 1.82e-03 | 30 | 62 | 2 | C1855520 | |
| Disease | cervical cancer (is_implicated_in) | 1.82e-03 | 30 | 62 | 2 | DOID:4362 (is_implicated_in) | |
| Disease | Hyperglycemia | 1.82e-03 | 30 | 62 | 2 | C0020456 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSQERTSDCIGSEGM | 881 | P29374 | |
| RTDNEEGCGMVKTSQ | 511 | Q9H175 | |
| GDTVNTASRMESNGE | 996 | P16066 | |
| ANSMAESREGDFGCT | 11 | P23634 | |
| ECMNGGEDFASQVTR | 256 | O14525 | |
| VGGMCERERSCSVNE | 366 | Q9H324 | |
| SGIDSCEMSDSGSQV | 1376 | Q6ZS30 | |
| GNEETCKMAREAGAT | 76 | Q8N3Y7 | |
| TDESAITQMCEVTGG | 191 | Q5JSJ4 | |
| DCFVVSEGANTMDIG | 391 | Q9UJ83 | |
| DSGDNGRMVCSIQDD | 376 | Q9Y5E7 | |
| RMQDTNVCGKEDFGD | 776 | Q8TDY2 | |
| MVQSGGCSANDSREV | 196 | Q9ULU8 | |
| EDNGCQMSDAVTVEV | 376 | Q8WUM0 | |
| SMVGNGDTTSQDDCV | 381 | Q6NYC1 | |
| GNCLSIAMETGDAED | 291 | Q7Z353 | |
| DLTSEGCLSDEQGMS | 981 | O60732 | |
| EESEGTGGQRSACAM | 496 | Q9NVR5 | |
| TCEMSNTLGTERGNV | 766 | Q6UXM1 | |
| GEECRMSGDLSSNVT | 486 | P35908 | |
| DNDFCGTDMTIGTDS | 166 | P17858 | |
| DNDFCGTDMTIGTDS | 166 | P08237 | |
| MGNASNDSQSEDCET | 1 | P43116 | |
| MAEASSANLGSGCEE | 1 | Q6P1K2 | |
| TQSDEENGRACEMNG | 61 | Q13422 | |
| RMSCQDEGCGLESEQ | 156 | O94916 | |
| DRDSGANGQVTCSLM | 376 | Q9Y5I3 | |
| RGNNEVVGGTDSSMD | 36 | O15350 | |
| MDSNLGEAASGCESE | 1361 | P38398 | |
| QMQSVCSDCNGEGEV | 181 | O60884 | |
| VRTSADGQAGNEEMV | 16 | O15072 | |
| VGQDSCQDSEGDMIF | 81 | Q8NFZ0 | |
| TGMSTVAKCDGERDD | 896 | Q9Y2F5 | |
| GDDRVCSANGFMTQT | 741 | Q14574 | |
| GMTSAGSDINECALD | 716 | P35555 | |
| QCPSANDSMGDERTA | 1041 | Q68DX3 | |
| GESDTQNMVSEEPCE | 806 | Q8TF40 | |
| EVVGVGDTCSFAQMD | 511 | Q7Z3C6 | |
| TSAGCGRFSQAMEVE | 516 | P29322 | |
| SDGNTDSCFNIDMET | 766 | Q8TDW7 | |
| ASQNAEMIETGSDCV | 61 | P08195 | |
| NATAGMETEGSCLEN | 736 | O60266 | |
| AASDGQVRMISCGAD | 576 | O60336 | |
| QDEGDMENTVSCSTP | 606 | Q5T1A1 | |
| DAGVTCSDGSNLEMR | 146 | Q86VB7 | |
| SCEIVSEGGNDSRMA | 646 | Q7Z5N4 | |
| SDLDSGDNGRVMCSI | 371 | Q9Y5E6 | |
| DSMEDEDAACGGQGQ | 556 | Q9Y2M0 | |
| AIDDDCNQTGQMTAG | 126 | P38117 | |
| IEIMDDCSTNCNGNG | 526 | Q9UKZ4 | |
| MSFRQGACVVTGSED | 416 | Q9H1Z4 | |
| CNSDSEQENISMVEG | 271 | Q8NEM2 | |
| RDSEAGAMEVNSIGN | 2126 | Q9P2P6 | |
| ESENCTTHNGGEMTE | 126 | Q6NSI8 | |
| RPEEQMESDNCSGGD | 321 | Q13501 | |
| DEQGRESKAATGACM | 141 | P55197 | |
| QRDTDMDGVGDQCDN | 821 | P07996 | |
| ASRCGIGQEEMEASS | 791 | Q9C0C2 | |
| VDCGSSGRKEMDNVS | 2101 | Q8IUG5 | |
| ARMQEDRDGSCSTVG | 11 | Q9NRM2 | |
| EGATDASMVEGDCQI | 121 | Q2M389 | |
| SATGETEGGDICMEE | 1081 | Q9UL36 | |
| RTESDQACGTMDTVD | 471 | Q13342 | |
| MTAVSSNRNPEDDGC | 1 | Q8N7P7 | |
| SQGESAEGMSQRCEE | 186 | P17097 | |
| ETEMEGEGNETGECT | 36 | P32418 |